• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS DUODENOVIDEOSCOPE Back to Search Results
Model Number JF-240
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pancreatitis (4481); Unspecified Hepatic or Biliary Problem (4493)
Event Date 11/01/2022
Event Type  Injury  
Event Description
Olympus reviewed the following literature titled "effect of ursodeoxycholic acid after self-expandable metal stent placement in malignant distal biliary obstruction: a propensity score¿matched cohort analysis".This multicenter retrospective study was to evaluate the efficacy of ursodeoxycholic acid (udca) in patients with self-expandable metallic stent (sems) for malignant distal biliary obstruction (mdbo) using a propensity score¿matched (psm) cohort analysis.A total of 354 patients were included (294 patients did not receive udca and 60 patients did receive udca).In the psm cohort, the sems occlusion rates in the control and udca groups were 5.5% and 18.2% at 3 months (p =.0732), 9.1% and 36.4% at 6 months (p =.0030), 14.5% and 40.0% at 12 months (p =.0049), and 18.2% and 41.8% after the complete period (p =.0119).Based on the univariate anal ysis results, udca administration (p z.0429) and 8-cm long sems (p =.13) were further assessed by multivariate analysis.In conclusion, administering udca after sems placement in patients with mdbo did not show efficacy for prolonging trbo.Patients receiving udca for more than a month might be at increased risk for sludge occlusion.Type of adverse events/number of patients [control group] (pancreatitis - 6 patients) mild - 4 patients, moderate - 2 patients, cholecystitis - 6 patients.[udca group] (pancreatitis - 2 patients) mild - 1 patient, moderate - 1 patient, cholecystitis - 5 patients, liver abscess - 1 patient.This literature article requires 3 reports.The related patient identifiers are as follows: (b)(4) / tjf-200, (b)(4) / jf-240, (b)(4) / tjf-260v.This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article https://doi.Org/10.1016/j.Gie.2022.10.038 provided for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Other relevant patient identifiers as follows: (b)(6).
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and correction to the initial with information inadvertently left out.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key17242675
MDR Text Key318342362
Report Number9610595-2023-09590
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K954451
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberJF-240
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/05/2023
Initial Date FDA Received06/30/2023
Supplement Dates Manufacturer Received07/07/2023
Supplement Dates FDA Received07/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-